This symposium will treat the impact of Artificial intelligence (AI) and Machine Learning (ML) on chemistry and biology, including drug design. The underlying theme of the discussions will be what we can now do with AI and ML that we couldn’t do before. For instance, is AI simply a new interpolation method in the old traditional computer-aided drug design (CADD)? Are the methods applied nowadays unreliable in contrast to the those applied in the early days? How can we combine the development and application of new materials with AI-generated knowledgebases? How much can AI help in the prediction and retro-synthesis of new chemical compounds, and how useful are these compounds? Still, the quality of published data matters as meaningful AI applications depend on the availability of high-quality test datasets.